To this end, we utilized a public data set of peripheral blood DNAm from pediatric participants, leveraging 5 validated clock algorithms to investigate the role of epigenetic, biological, and telomere-linked age acceleration in AD patients compared to healthy subjects. This evidence concerns the gene CLOCK and Alzheimer disease.